Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative? [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
across the European Union, enabling faster, standardized biomarker testing with minimal hands-on time. This certification not only broadens Ella's potential adoption in hospitals and clinical labs, but also positions the platform as a foundation for in-house test development and future diagnostic applications using Bio-Techne's extensive Simple Plex assay portfolio. Next, we'll explore how Ella's CE-IVD approval in the EU may reshape Bio-Techne's investment narrative by strengthening its clinical footprint. Uncover the next big thing with 31 elite penny stocks that balance risk and reward. Bio-Techne Investment Narrative Recap To own Bio-Techne, you need to believe its tools and diagnostics can remain essential even as funding and tariff headwinds pressure demand and margins. Ella's CE-IVD approval in the EU slightly strengthens the near term catalyst around expanding clinical adoption, but it does not remove the bigger risk of weaker spending from pharma, biotech, and acade
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- 3 Reasons to Avoid TECH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Corporation (TECH) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Middle East DNA Synthesis Market Research Report 2026: $7.6 Bn Industry Trends and Forecasts to 2035 - Precision Medicine, Molecular Diagnostics and Biopharma R&D Investments Accelerate Demand [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections [Yahoo! Finance]Yahoo! Finance
- Bio-Techne to Present at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 2/4/26 - Beat
TECH
Sec Filings
- 3/4/26 - Form 3
- 3/4/26 - Form 4
- 2/19/26 - Form 4
- TECH's page on the SEC website